We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.29%
2 Financials 4.55%
3 Industrials 4.18%
4 Healthcare 4.08%
5 Consumer Discretionary 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FG
8176
DELISTED
FGL Holdings Ordinary Shares
FG
$152K ﹤0.01%
14,288
-593,146
-98% -$5.39M
FTR
8177
PUT
DELISTED
Frontier Communications Corp.
FTR
$152K ﹤0.01%
170,900
+22,100
+15% +$18K
ABEO icon
8178
PUT
Abeona Therapeutics
ABEO
$341M
$151K ﹤0.01%
1,848
+168
+10% +$11.9K
APRN
8179
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$151K ﹤0.01%
1,917
-4,275
-69% -$389K
CPRX
8180
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$150K ﹤0.01%
40,100
-3,000
-7% -$14K
LFCR icon
8181
Lifecore Biomedical
LFCR
$179M
$150K ﹤0.01%
13,255
-5,017
-27% -$53.4K
NSLR
8182
CALL
Neostellar Capital Corp
NSLR
$278M
$150K ﹤0.01%
27,280
-14,296
-34% -$78.6K
XNET
8183
CALL
Xunlei
XNET
$334M
$150K ﹤0.01%
30,600
+1,300
+4% +$5.64K
ICOL
8184
DELISTED
iShares MSCI Colombia ETF
ICOL
$150K ﹤0.01%
10,787
-5,309
-33% -$69.7K
DPLO
8185
CALL
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$150K ﹤0.01%
+37,600
New +$177K
QUAD icon
8186
PUT
Quad
QUAD
$513M
$149K ﹤0.01%
32,000
+7,500
+31% +$46.9K
MRNS
8187
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$149K ﹤0.01%
17,241
-5,601
-25% -$31.4K
MGIC
8188
DELISTED
Magic Software Enterprises
MGIC
$148K ﹤0.01%
+15,177
New +$145K
UEC icon
8189
Uranium Energy
UEC
$5.55B
$148K ﹤0.01%
160,752
-124,565
-44% -$121K
EGIO
8190
PUT
DELISTED
Edgio, Inc. Common Stock
EGIO
$148K ﹤0.01%
908
+253
+39% +$40.1K
KYN icon
8191
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$147K ﹤0.01%
10,528
-543
-5% -$7.23K
MNKD icon
8192
CALL
MannKind Corp
MNKD
$1.24B
$147K ﹤0.01%
114,300
+91,200
+395% +$117K
TZOO icon
8193
Travelzoo
TZOO
$73.4M
$147K ﹤0.01%
+13,753
New +$143K
KA
8194
CALL
DELISTED
Kineta, Inc. Common Stock
KA
$147K ﹤0.01%
+461
New +$104K
ZBIO
8195
DELISTED
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
$147K ﹤0.01%
16,056
-1,390
-8% -$16.9K
ACH
8196
CALL
Accendra Health
ACH
$73.1M
$146K ﹤0.01%
28,300
+1,500
+6% +$9.63K
OPK icon
8197
CALL
Opko Health
OPK
$1.03B
$146K ﹤0.01%
99,100
+10,700
+12% +$17.9K
UXIN
8198
CALL
Uxin Ltd
UXIN
$260M
$146K ﹤0.01%
644
+111
+21% +$30K
CSLT
8199
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$146K ﹤0.01%
110,016
-122,900
-53% -$171K
FF icon
8200
Future Fuel
FF
$245M
$145K ﹤0.01%
+11,733
New +$140K

Similar funds

Ken Griffin's Q4 2019 Portfolio in Review

As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.

  • Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
  • Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Ken Griffin opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.